Product Information

ATOVAQUONE 750 MG/5 ML SUSP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.7561 per ML under NDC 68462042121. Its NADAC has been published 393 times since Feb 13, 2019.

FDA first approved this application on Nov 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATOVAQUONE 750 MG/5 ML SUSP

atovaquone
$0.7561per ML

Strength

750 mg/5mL

NDC

68462042121

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ATOVAQUONE

Approval Type

Generic (ANDA)

FDA Application

ANDA209685

FDA Approved

11/21/2018

TE Code

AB

On Market Since

12/31/2017

Pharmacological Classes

Price Statistics

The NADAC for ATOVAQUONE 750 MG/5 ML SUSP has been published 393 times since Feb 13, 2019, and over the history we have for it it has declined 71.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7561 per ML
All-time high$3.1757 (Nov 13, 2019)
All-time low$0.6842 (Jul 22, 2026)
52-week high$0.8766
52-week low$0.6842
Median price$1.0779
Average price$1.2730
Largest weekly change+55.5% (Jan 20, 2021)
Weeks tracked393
Tracking sinceFeb 13, 2019

Price History

1W

+10.5%

1M

+10.5%

3M

+9.4%

6M

+1.9%

1Y

-12.4%

3Y

-20.6%

5Y

-45.3%

All

-71.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATOVAQUONE 750 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE 750 MG/5 ML SUSP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.7561 per ML (NDC 68462042121), effective Aug 19, 2026.

How has the price of ATOVAQUONE 750 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has declined 71.2%. It has been tracked across 393 weekly CMS publications since Feb 13, 2019.

What are the highest and lowest recorded NADAC prices for ATOVAQUONE 750 MG/5 ML SUSP?

Since Feb 13, 2019, the NADAC for ATOVAQUONE 750 MG/5 ML SUSP has ranged from a low of $0.6842 (Jul 22, 2026) to a high of $3.1757 (Nov 13, 2019), with a median of $1.0779 per ML.

Are there cheaper alternatives to ATOVAQUONE 750 MG/5 ML SUSP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATOVAQUONE 750 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures ATOVAQUONE 750 MG/5 ML SUSP?

ATOVAQUONE 750 MG/5 ML SUSP (NDC 68462042121) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.